NovaBridge Biosciences: cash_and_restricted_cash
| Value | {"unit": "CNY", "value": 2960017000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"} |
|---|---|
| Period | (as of 2020-09-30) |
| Status | superseded |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/70b8296e-e478-44d0-8e4f-5d9d8cf7e16c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-030570Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/cash-and-restricted-cash/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/70b8296e-e478-44d0-8e4f-5d9d8cf7e16c
History
- no predecessors — first report